{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Diseases+Hereditary&page=34", "query": { "condition": "Eye Diseases Hereditary", "page": 34 }, "page_size": 10 }, "pagination": { "page": 34, "page_size": 10, "total_count": 808, "total_pages": 81, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Diseases+Hereditary&page=35&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Eye+Diseases+Hereditary&page=33&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T23:46:36.185Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02839720", "title": "Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cutaneous Neurofibroma", "Neurofibromatosis Type 1", "Optic Nerve Glioma" ], "interventions": [ { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Selumetinib Sulfate", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2017-08-26", "completion_date": "2023-08-31", "has_results": true, "last_update_posted_date": "2023-12-06", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 2, "location_summary": "Birmingham, Alabama • Bethesda, Maryland", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02839720" }, { "nct_id": "NCT04947124", "title": "A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sturge-Weber Syndrome (SWS)", "Glaucoma", "Glaucoma Congenital", "Ocular Hypertension" ], "interventions": [ { "name": "QLS-101ophthalmic solution 1%", "type": "DRUG" }, { "name": "QLS-101ophthalmic solution 2%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Qlaris Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2021-10-19", "completion_date": "2022-08-01", "has_results": false, "last_update_posted_date": "2025-01-20", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04947124" }, { "nct_id": "NCT03444961", "title": "Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Retinitis Pigmentosa" ], "interventions": [ { "name": "CAREN system training", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "25 Years to 100 Years" }, "enrollment_count": 4, "start_date": "2018-01-30", "completion_date": "2018-06-20", "has_results": true, "last_update_posted_date": "2021-07-14", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03444961" }, { "nct_id": "NCT06275620", "title": "A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "X-Linked Retinitis Pigmentosa" ], "interventions": [ { "name": "AGTC-501 (high dose and standard corticosteroid regimen)", "type": "BIOLOGICAL" }, { "name": "AGTC-501 (low dose and standard corticosteroid regimen)", "type": "BIOLOGICAL" }, { "name": "AGTC-501 (high dose and modified corticosteroid regimen)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Beacon Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "MALE", "summary": "12 Years and older · Male only" }, "enrollment_count": 24, "start_date": "2023-11-14", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2024-10-30", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 7, "location_summary": "Jacksonville, Florida • Miami, Florida • Boston, Massachusetts + 4 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06275620" }, { "nct_id": "NCT00000133", "title": "Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Retinopathy of Prematurity" ], "interventions": [ { "name": "Trans-scleral Cryotherapy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "1 Year", "sex": "ALL", "summary": "Up to 1 Year" }, "enrollment_count": null, "start_date": "1986-01", "completion_date": "2003-08", "has_results": false, "last_update_posted_date": "2014-02-04", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Washington D.C., District of Columbia • Miami, Florida + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000133" }, { "nct_id": "NCT04890132", "title": "Vestibular Precision: Physiology & Pathophysiology", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vestibular Schwannoma", "Inner Ear Disease", "Dizziness", "Neurofibromatosis 2", "Vestibular Disorder" ], "interventions": [ { "name": "VOR precision training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts Eye and Ear Infirmary", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "8 Years to 80 Years" }, "enrollment_count": 90, "start_date": "2020-07-01", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2023-03-16", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04890132" }, { "nct_id": "NCT02375971", "title": "RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Retinopathy of Prematurity" ], "interventions": [ { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Laser therapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 224, "start_date": "2015-12-30", "completion_date": "2017-12-14", "has_results": true, "last_update_posted_date": "2018-11-14", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 12, "location_summary": "Loma Linda, California • Sacramento, California • Aurora, Colorado + 9 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02375971" }, { "nct_id": "NCT01866371", "title": "High Resolution Retinal Imaging", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stargardts", "Retinitis Pigmentosa", "Age-related Macular Degeneration", "Choroideremia", "Geographic Atrophy" ], "interventions": [ { "name": "Retinal imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 600, "start_date": "2013-05", "completion_date": "2031-12", "has_results": false, "last_update_posted_date": "2026-05-05", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01866371" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" }, { "nct_id": "NCT05246904", "title": "Validating a Self-fitting Hearing Aid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hearing and Vision Loss" ], "interventions": [ { "name": "Fitting algorithm", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 41, "start_date": "2022-03-17", "completion_date": "2023-02-28", "has_results": false, "last_update_posted_date": "2023-04-25", "last_synced_at": "2026-10-16T23:46:36.185Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05246904" } ] }